Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDS

Clinical trial NCT04366115 · NOT_YET_RECRUITING

Trial details

NCT number: NCT04366115
Sponsor: AVM Biotechnology Inc
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

ARDS Covid19 Influenza, Human

Start date: 2026-12-01
Primary completion: 2031-12-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.